Researchers at Niigata University have used advanced three-dimensional (3D) imaging to reveal how amyloid β (Aβ) deposits ...

While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in ...

Scientists have made a breakthrough in understanding how Alzheimer’s disease develops, and a decades-old drug could be the ...

Researchers used CAR T therapy to target beta amyloid plaques in Alzheimer’s disease. In mice, the modified immune cells ...

By far the strongest genetic risk factor for Alzheimer’s disease is a variant of apolipoprotein E, or ApoE. People who carry ...

Add Yahoo as a preferred source to see more of our stories on Google. An illustration depicts cells in an Alzheimer’s-affected brain, with abnormal levels of beta amyloid protein clumping together to ...

By Hugo Francisco de Souza A novel CAR-T cell approach targets amyloid plaques in preclinical Alzheimer models, raising the ...

Indiana University School of Medicine scientists have identified a promising drug target for Alzheimer's disease. The team ...

Is the IDOL enzyme the key to stopping Alzheimer's? New research shows that blocking this single target can dissolve brain plaques and boost cognitive resilience.

Studies reveal the therapeutic mechanism of action for levetiracetam to prevent the production of Aβ and, consequently, downstream irreversible damage.

To consolidate memories, our brains replay them during periods of rest as a kind of 'replay mode'. A new mouse study suggests ...

Researchers at Niigata University used advanced three-dimensional imaging to reveal how amyloid β deposits spread along blood ...